10-Year Phase III Trial Confirms Two-Week Radiotherapy as Safe and Effective as Traditional Eight-Week Course for Prostate Cancer
In a landmark advancement in prostate cancer treatment, a pivotal phase III clinical trial has demonstrated that a condensed course ...
